Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.

CYAD-01 - Celdara Medical, Celyad Oncology

CYAD-02 - Celyad Oncology

http://www.ncbi.nlm.nih.gov/pubmed/40954213

Anne Flament; Caroline Lonez; Daniel Pollyea; David A Sallman; Dries Deeren; Eytan Breman; Sébastien Anguille; Tara L Lin; Tessa Kerre; William G Blum; Yves Beguin

Sep 16, 2025